EUVIMEDEUVIMED entdecken
Crossref

Catheter Ablation for Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy

Shuyu Jin, Mengmeng Li, Chenxi Jiang, Ribo Tang, Caihua Sang, Wei Wang, Xin Zhao, Changyi Li, Songnan Li, Xueyuan Guo, Changqi Jia, Man Ning und 14 weitere

JACC: Clinical Electrophysiology · 2025-10 · 11 (10) · 2151-2164

DOI: 10.1016/j.jacep.2025.05.028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JACC: Clinical Electrophysiology, 2025-10. Verfasst von Shuyu Jin und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Center for Cardiovascular Diseases, Beijing…. Hauptthemen laut MEDLINE: Tachycardia, Ventricular, Cardiomyopathy, Hypertrophic, Catheter Ablation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Studies on catheter ablation of hypertrophic cardiomyopathy (HCM)- ventricular tachycardia (VT) are relatively limited and mainly focused on feasibility and safety, whereas the VT distribution and electrophysiological properties remain insufficiently characterized. OBJECTIVES: The aim of this study was to detail the site-specific electrophysiological properties and ablation outcomes in HCM-VT. METHODS: A total of 32 patients with HCM-VT who underwent catheter ablation were included. Through endocardial and epicardial mapping, their arrhythmogenic substrate and re-entrant circuit were identified and analyzed. RESULTS: Combined endocardial/epicardial mapping was performed in 29 of the 32 patients. Twenty-eight VTs were induced among 25 patients, including 25 scar-mediated re-entries, 2 focal origins, and one bundle branch re-entry. Twenty-five re-entries were localized to the left ventricular (LV) lateral wall (9 of 25), apical aneurysm (6 of 25), superior basal regions (8 of 25), interventricular septum (1 of 25), and papillary muscle (1 of 25), respectively. Incomplete activation sequences were recorded across regions: LV lateral wall (epicardium: 54.3% ± 11.7%; endocardium: 35.9% ± 15.5%), apical aneurysm (endocardium: 40.3% ± 25.0%; epicardium: 32.7% ± 22.6%), and superior basal regions (endocardium: 25.5% ± 7.7%; epicardium: 27.2% ± 11.4%). Over a median follow-up of 31 months, the long-term VT-free survival rate after the index procedure was 73.3% in the LV lateral wall, 83.3% in the apical aneurysm, and 0% in the LV superior basal region and septum, which was consistent with the extent of mid-myocardial involvement. The VT-free survival rate after multiple procedures was 71.9% in all patients. CONCLUSIONS: HCM-VTs were primarily three-dimensional re-entrant circuits with mid-myocardial involvement. Procedural success largely depended on the origin and extent of intramural involvement of VT re-entry.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tachycardia, VentricularCardiomyopathy, HypertrophicCatheter AblationHumansFemaleMaleMiddle AgedTreatment OutcomeAgedAdultEpicardial MappingRetrospective Studies

Stichwörter der Autor:innen

catheter ablationhypertrophic cardiomyopathythree-dimensional re-entrant circuitsventricular tachycardia

Autor:innen und Institutionen

  • Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Center for Cardiovascular Diseases, Beijing, China.
  • Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Center for Cardiovascular Diseases, Beijing, China. Electronic address: dragon2008@vip.sina.com.
  • Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Center for Cardiovascular Diseases, Beijing, China; Department of Cardiology, The First Affiliated Hospital of Zh…

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Jin, S., Li, M., Jiang, C., Tang, R., Sang, C., Wang, W., Zhao, X., Li, C., Li, S., Guo, X., Jia, C., Ning, M., Feng, L., Wen, D., Zhu, H., Liu, T., Jiang, Y., Liu, F., Jiang, C., …, & Ma, C. (2025). Catheter Ablation for Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy. JACC: Clinical Electrophysiology, 11(10), 2151-2164. https://doi.org/10.1016/j.jacep.2025.05.028

Vancouver

Jin S, Li M, Jiang C, Tang R, Sang C, Wang W, et al. Catheter Ablation for Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy. JACC: Clinical Electrophysiology. 2025;11(10):2151-2164. doi:10.1016/j.jacep.2025.05.028

BibTeX
@article{Jin2025,
  author = {Jin, Shuyu and Li, Mengmeng and Jiang, Chenxi and Tang, Ribo and Sang, Caihua and Wang, Wei and Zhao, Xin and Li, Changyi and Li, Songnan and Guo, Xueyuan and Jia, Changqi and Ning, Man and Feng, Li and Wen, Dan and Zhu, Hui and Liu, Tong and Jiang, Yuexin and Liu, Fang and Jiang, Chao and Zhou, Ning and Han, Kangning and Yang, Jie and Long, Deyong and Du, Xin and Dong, Jianzeng and Ma, Changsheng},
  title = {Catheter Ablation for Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy},
  journal = {JACC: Clinical Electrophysiology},
  year = {2025},
  volume = {11},
  number = {10},
  pages = {2151--2164},
  doi = {10.1016/j.jacep.2025.05.028}
}
Kostenlos starten →